Back to User profile » Dr Kavita Nair
Papers published by Dr Kavita Nair:
Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis
Foley JF, Nair KV, Vollmer T, Stephenson JJ, Niecko T, Agarwal SS, Watson C
Patient Preference and Adherence 2017, 11:1035-1048
Published Date: 16 June 2017
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ
Diabetes, Metabolic Syndrome and Obesity 2016, 9:233-241
Published Date: 2 August 2016
The cost of inpatient death associated with acute coronary syndrome
Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV
Vascular Health and Risk Management 2016, 12:13-21
Published Date: 3 February 2016
Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both
Ghushchyan V, Nair KV, Page RL II
Vascular Health and Risk Management 2015, 11:25-34
Published Date: 24 December 2014
Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
Page RL 2nd, Ghushchyan V, Allen RR, Roper L, Beck D, Johnathan BH, Frech-Tamas F, Chan W, McQueen RB, Nair KV
Drug, Healthcare and Patient Safety 2012, 4:67-74
Published Date: 10 July 2012
An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
Pesa JA, Van Den Bos J, Gray T, Hartsig C, McQueen RB, Saseen JJ, Nair KV
Patient Preference and Adherence 2012, 6:63-72
Published Date: 18 January 2012
Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey
Nair KV, Belletti D, Doyle J, Allen R, McQueen R, Saseen J, Griend J, Patel J, McQueen A, Jan S
Patient Preference and Adherence 2011, 5:195-206
Published Date: 29 April 2011